|
|
| | L-Leucine, L-phenylalanyl-L-asparaginyl-L-tryptophyl-L-α-aspartyl-L-tyrosyl-L-seryl-L-tryptophyl-L-lysyl-L-seryl-L-α-glutamyl-L-arginyl-L-leucyl-L-lysyl-L-α-glutamyl-L-alanyl-L-tyrosyl-L-α-aspartyl- Basic information |
| | L-Leucine, L-phenylalanyl-L-asparaginyl-L-tryptophyl-L-α-aspartyl-L-tyrosyl-L-seryl-L-tryptophyl-L-lysyl-L-seryl-L-α-glutamyl-L-arginyl-L-leucyl-L-lysyl-L-α-glutamyl-L-alanyl-L-tyrosyl-L-α-aspartyl- Chemical Properties |
| density | 1.49±0.1 g/cm3(Predicted) | | form | Solid | | color | White to off-white | | Sequence | Phe-Asn-Trp-Asp-Tyr-Ser-Trp-Lys-Ser-Glu-Arg-Leu-Lys-Glu-Ala-Tyr-Asp-Leu |
| | L-Leucine, L-phenylalanyl-L-asparaginyl-L-tryptophyl-L-α-aspartyl-L-tyrosyl-L-seryl-L-tryptophyl-L-lysyl-L-seryl-L-α-glutamyl-L-arginyl-L-leucyl-L-lysyl-L-α-glutamyl-L-alanyl-L-tyrosyl-L-α-aspartyl- Usage And Synthesis |
| Uses | Human PD-L1 inhibitor I is a hPD-1 peptide ligand, with a KD of 3.39 μM. Human PD-L1 inhibitor I may disturb the binding of hPD-L1 to hPD-1[1]. | | References | [1] Tianyu Wang, et al. Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway. J Med Chem. 2019 Feb 28;62(4):1715-1730. DOI:10.1021/acs.jmedchem.8b00990 |
| | L-Leucine, L-phenylalanyl-L-asparaginyl-L-tryptophyl-L-α-aspartyl-L-tyrosyl-L-seryl-L-tryptophyl-L-lysyl-L-seryl-L-α-glutamyl-L-arginyl-L-leucyl-L-lysyl-L-α-glutamyl-L-alanyl-L-tyrosyl-L-α-aspartyl- Preparation Products And Raw materials |
|